Waters appoints new CEO

Skip to Navigation


  • Published: Jun 26, 2015
  • Author: Jon Evans
  • Source: Waters Corporation
  • Suppliers: Waters Corporation
  • Channels: Proteomics & Genomics / Gas Chromatography / HPLC / Sample Preparation / Ion Chromatography / Electrophoresis / Detectors / Laboratory Informatics / Proteomics / Infrared Spectroscopy / Chemometrics & Informatics / X-ray Spectrometry / Atomic / UV/Vis Spectroscopy / MRI Spectroscopy / NMR Knowledge Base / Raman / Base Peak
thumbnail image: Waters appoints new CEO

Waters Corporation has appointed Christopher O'Connell, formerly at US medical device company Medtronic, as its new president and chief executive officer (CEO).

‘From the outset, Waters' Board of Directors focused on identifying a new CEO whose experience best supports the continuation of Waters' culture, business strategies and performance drivers,’ explained Thomas Salice, lead director for Waters Corporation. ‘Chris O'Connell's wide range of experiences across all aspects of a technology-focused global organization prepares him well for the Waters CEO position. Through the process of getting to know him, we found a leader who reflects Waters' core values in addition to being an extremely motivated, thoughtful and engaging person. We are confident Chris is the right person to continue to drive Waters’ leadership performance and chart its future direction.’

‘I am thrilled to join Waters Corporation,’ said O'Connell. ‘Not only am I excited to enter an industry that enables its customers to advance and push the limits of science, but I’m very proud to join the industry's technology and customer support leader, and to be given the opportunity to lead a remarkable group of people.’

Over his 21 years at Medtronic, O'Connell held a variety of leadership positions, most recently as president of the Restorative Therapies Group, responsible for $7 billion in revenue and more than 16,000 employees worldwide. He provided overall strategic direction and operational management of the group’s five divisions, as well as led the integration of the group’s activities within the overall strategy of the company. Chris earned a Bachelor’s degree from Northwestern University and a Master’s degree in Business Administration from Harvard University.

Retiring CEO Douglas Berthiaume will continue in his role as chairman of Waters' Board of Directors, while all other leadership positions within Waters will remain in place. ‘With this leadership transition, it is important to recognize Doug Berthiaume for all that he accomplished as Waters' president, CEO and chairman of the Board,’ said Salice. ‘As the leading architect of the company's focused business strategy, Doug oversaw Waters’ drive to expand applications of our core technologies and commitment to customer relationships. Impressively, the corporation has experienced a 35-fold increase in share value since Doug led the effort taking the company public in November 1995. We offer our heartfelt gratitude to Doug and look forward to his continued role as chairman.’

(Photo of Christopher O'Connell courtesy of Medtronic.)

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in separation science? Visit our sister site separationsNOW.com

Copyright © 2018 John Wiley & Sons, Inc. All Rights Reserved